Literature DB >> 33912676

Cannabis and the Gut-Brain Axis Communication in HIV Infection.

Natalie L Wilson1, Scott N Peterson2, Ronald J Ellis3.   

Abstract

People living with HIV infection (PWH) disclose that cannabis is an effective strategy for alleviating symptoms associated with HIV disease. However, some medical providers feel ill-informed to engage in evidence-based conversations. HIV leads to alterations in the gut microbiome, gut-brain axis signaling, and chronic inflammation. The endocannabinoid system regulates homeostasis of multiple organ systems. When deficient, dysregulation of the gut-brain axis can result in chronic inflammation and neuroinflammation. Cannabis along with the naturally occurring endocannabinoids has antioxidant and anti-inflammatory properties that can support healing and restoration as an adjunctive therapy. The purpose of this literature review is to report the physiologic mechanisms that occur in the pathology of HIV and discuss potential benefits of cannabinoids in supporting health and reducing the negative effects of comorbidities in PWH. Copyright 2021, Mary Ann Liebert, Inc., publishers.

Entities:  

Keywords:  HIV; cannabis; endocannabinoids; gut–brain axis; microbiome

Mesh:

Year:  2021        PMID: 33912676      PMCID: PMC8064951          DOI: 10.1089/can.2020.0037

Source DB:  PubMed          Journal:  Cannabis Cannabinoid Res        ISSN: 2378-8763


  99 in total

Review 1.  Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue.

Authors:  P D Cani
Journal:  Clin Microbiol Infect       Date:  2012-07       Impact factor: 8.067

Review 2.  Biodegradable polymeric nanoparticles based drug delivery systems.

Authors:  Avnesh Kumari; Sudesh Kumar Yadav; Subhash C Yadav
Journal:  Colloids Surf B Biointerfaces       Date:  2009-09-08       Impact factor: 5.268

Review 3.  HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.

Authors:  Corbin G Thompson; Cynthia L Gay; Angela D M Kashuba
Journal:  AIDS Res Hum Retroviruses       Date:  2017-05-16       Impact factor: 2.205

4.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.

Authors:  Hubert Plovier; Amandine Everard; Céline Druart; Clara Depommier; Matthias Van Hul; Lucie Geurts; Julien Chilloux; Noora Ottman; Thibaut Duparc; Laeticia Lichtenstein; Antonis Myridakis; Nathalie M Delzenne; Judith Klievink; Arnab Bhattacharjee; Kees C H van der Ark; Steven Aalvink; Laurent O Martinez; Marc-Emmanuel Dumas; Dominique Maiter; Audrey Loumaye; Michel P Hermans; Jean-Paul Thissen; Clara Belzer; Willem M de Vos; Patrice D Cani
Journal:  Nat Med       Date:  2016-11-28       Impact factor: 53.440

5.  Gut epithelial barrier and systemic inflammation during chronic HIV infection.

Authors:  Ma Somsouk; Jacob D Estes; Claire Deleage; Richard M Dunham; Rebecca Albright; John M Inadomi; Jeffrey N Martin; Steven G Deeks; Joseph M McCune; Peter W Hunt
Journal:  AIDS       Date:  2015-01-02       Impact factor: 4.177

6.  The gut microbiota influences blood-brain barrier permeability in mice.

Authors:  Viorica Braniste; Maha Al-Asmakh; Czeslawa Kowal; Farhana Anuar; Afrouz Abbaspour; Miklós Tóth; Agata Korecka; Nadja Bakocevic; Lai Guan Ng; Ng Lai Guan; Parag Kundu; Balázs Gulyás; Christer Halldin; Kjell Hultenby; Harriet Nilsson; Hans Hebert; Bruce T Volpe; Betty Diamond; Sven Pettersson
Journal:  Sci Transl Med       Date:  2014-11-19       Impact factor: 17.956

7.  The mucosal barrier and immune activation in HIV pathogenesis.

Authors:  Jason M Brenchley; Daniel C Douek
Journal:  Curr Opin HIV AIDS       Date:  2008-05       Impact factor: 4.283

8.  Microbial translocation is a cause of systemic immune activation in chronic HIV infection.

Authors:  Jason M Brenchley; David A Price; Timothy W Schacker; Tedi E Asher; Guido Silvestri; Srinivas Rao; Zachary Kazzaz; Ethan Bornstein; Olivier Lambotte; Daniel Altmann; Bruce R Blazar; Benigno Rodriguez; Leia Teixeira-Johnson; Alan Landay; Jeffrey N Martin; Frederick M Hecht; Louis J Picker; Michael M Lederman; Steven G Deeks; Daniel C Douek
Journal:  Nat Med       Date:  2006-11-19       Impact factor: 53.440

9.  An altered intestinal mucosal microbiome in HIV-1 infection is associated with mucosal and systemic immune activation and endotoxemia.

Authors:  S M Dillon; E J Lee; C V Kotter; G L Austin; Z Dong; D K Hecht; S Gianella; B Siewe; D M Smith; A L Landay; C E Robertson; D N Frank; C C Wilson
Journal:  Mucosal Immunol       Date:  2014-01-08       Impact factor: 7.313

10.  Prevention of Diet-Induced Obesity Effects on Body Weight and Gut Microbiota in Mice Treated Chronically with Δ9-Tetrahydrocannabinol.

Authors:  Nina L Cluny; Catherine M Keenan; Raylene A Reimer; Bernard Le Foll; Keith A Sharkey
Journal:  PLoS One       Date:  2015-12-03       Impact factor: 3.240

View more
  3 in total

Review 1.  Toward Composite Pain Biomarkers of Neuropathic Pain-Focus on Peripheral Neuropathic Pain.

Authors:  Monica M Diaz; Jacob Caylor; Irina Strigo; Imanuel Lerman; Brook Henry; Eduardo Lopez; Mark S Wallace; Ronald J Ellis; Alan N Simmons; John R Keltner
Journal:  Front Pain Res (Lausanne)       Date:  2022-05-11

2.  Marijuana Use and Health Outcomes in Persons Living With HIV: Protocol for the Marijuana Associated Planning and Long-term Effects (MAPLE) Longitudinal Cohort Study.

Authors:  Angel B Algarin; Gabriela N Plazarte; Kaitlin R Sovich; Stella D Seeger; Yancheng Li; Ronald A Cohen; Catherine W Striley; Bruce A Goldberger; Yan Wang; Charurut Somboonwit; Gladys E Ibañez; Emma C Spencer; Robert L Cook
Journal:  JMIR Res Protoc       Date:  2022-08-30

Review 3.  The Link between Cannabis Use, Immune System, and Viral Infections.

Authors:  Sanjay B Maggirwar; Jag H Khalsa
Journal:  Viruses       Date:  2021-06-09       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.